DANZITEN vs SORAFENIB TOSYLATE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. DANZITEN and SORAFENIB TOSYLATE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	DANZITEN	SORAFENIB TOSYLATE
Rating	70/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	NILOTINIB TARTRATE	SORAFENIB TOSYLATE
Manufacturer	Azurity	Yabao Pharm
Dosage forms	Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	Boxed warning	None
Treats	Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors	Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Neoplasms

danziten sorafenib tosylate

Rating

70/100

New

Pharmacy pays

—

Type

Active ingredient

NILOTINIB TARTRATE

SORAFENIB TOSYLATE

Manufacturer

Azurity

Yabao Pharm

Dosage forms

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors

Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Neoplasms

Frequently asked questions

What is the difference between Danziten and Sorafenib Tosylate?

Danziten contains Nilotinib Tartrate, while Sorafenib Tosylate contains Sorafenib Tosylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.